Proteases
Proteases, also known as peptidases or proteolytic enzymes, consists of a large number of enzymes catalyzing the hydrolysis of peptide bonds and subsequently resulting in the degradation of protein substrates into amino acids. Proteases are involved in a wide range of human diseases, including cancer, neurodegenerative disorders, inflammatory diseases and cardiovascular diseases. Thus numerous proteases inhibitors (small molecules and proteins) have been identified to block activity of proteases. Proteases inhibitors can be classified into different types based on the class of proteases they inhibit through two general mechanisms, irreversible “trapping” reactions and reversible tight-binding reactions. Proteases inhibitors have been used as diagnostic or therapeutic agents for the treatment of proteases-related diseases.
-
A1038 Amyloid β-Peptide (10-20) (human)Summary: Initiates neurodegeneration in Alzheimer disease
-
B4686 TAPI-12 CitationTarget: MMPSummary: TACE/ADAM17 inhibitor
-
C5598 MMP-2/MMP-9 Inhibitor ISummary: potent inhibitor of matrix metalloproteinase-2 (MMP-2) and MMP-9
-
C5615 MMP-2 Inhibitor ISummary: reversible inhibitor of matrix metalloproteinase (MMP)-2
-
C5818 MMP-2 Inhibitor IISummary: irreversible inhibitor of MMP-2